Most recently, it's been discovered that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in similar parts as classical opioid receptors, it binds to the big range of endogenous opioids. Not like most opioid receptors, this receptor acts as being a scavenger https://torreyz570yvv1.blogars.com/profile